GENERATE - 下一代妇科生态手术 - 妇科适应症的机器人辅助手术 (GENERATE)
GENERATE - Next GENERATION of GynEcological Surgery - 妇科适应症的机器人辅助手术 - 一项前瞻性、非介入性、多中心、上市后临床研究
GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications
Generate real-world evidence in the use of the da Vinci Surgical Systems for gynecological indications within the German health care system.
研究概览
详细说明
A prospective, non-interventional, multi-center, post market clinical study.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Petra Kremer
- 电话号码:+49 151 62679136
- 邮箱:petra.kremer@intusurg.com
研究联系人备份
- 姓名:Peter Appenrodt
- 电话号码:+49 173 2043740
- 邮箱:peter.appenrodt@intusurg.com
学习地点
-
-
-
Berlin、德国、13353
- 主动,不招人
- Charité - Universitätsmedizin Berlin - Klinik für Gynäkologie
-
Bochum、德国、44791
- 主动,不招人
- Augusta-Kranken-Anstalt Bochum
-
Coburg、德国、96450
- 主动,不招人
- Sana Kliniken Coburg
-
Cologne、德国、50935
- 终止
- St. Elisabeth-Krankenhaus Köln-Hohenlind
-
Essen、德国、45147
- 主动,不招人
- Universitätsklinikum Essen
-
Frankfurt am Main、德国、60431
- 主动,不招人
- Agaplesion Markus Krankenhaus Frankfurt am Main
-
Freiburg im Breisgau、德国、79106
- 招聘中
- Universitätsklinikum Freiburg - Klinik für Frauenheilkunde
-
接触:
- Markus Hübner, Prof. Dr.
-
Greifswald、德国、17475
- 招聘中
- Universitätsmedizin Greifswald
-
接触:
- Zaher Alwafai, Dr.
- 电话号码:+49 3834 86 6500
- 邮箱:zaher.alwafai@med.uni-greifswald.de
-
Höxter、德国、37671
- 主动,不招人
- St. Ansgar Krankenhaus Höxter
-
Kiel、德国、24105
- 主动,不招人
- Universitätsklinikum Kiel
-
Nuremberg、德国、90419
- 主动,不招人
- Klinikum Nürnberg Nord / Klinik für Frauenheilkunde
-
Schwerin、德国、19055
- 主动,不招人
- Helios Kliniken Schwerin
-
Tübingen、德国、72076
- 主动,不招人
- Universitätsklinikum Tübingen - Frauenklinik
-
-
Free and Hanseatic City of Hamburg
-
Hamburg、Free and Hanseatic City of Hamburg、德国、22457
- 主动,不招人
- Albertinen Krankenhaus Hamburg
-
-
Hesse
-
Wiesbaden、Hesse、德国、65189
- 主动,不招人
- St. Josefs-Hospital Wiesbaden
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients with gynecological disease that may be treated by surgical intervention.
描述
Key Inclusion Criteria:
- Woman with 18 years of age or older
- Patient is willing to participate and to comply with the study procedures as demonstrated by signing the informed consent
- Patient is a candidate for a gynecological procedure to be performed with the Intuitive Surgical System
Key Exclusion Criteria:
- Life expectancy of less than 1 year
- Pregnancy, or positive pregnancy test for women prior to menopause or breastfeeding women
- Current participation in a clinical study, if not pre-approved by Intuitive
- Individuals who are unable to fully understand all aspects of the study that are relevant to the decision to participate (mentally or verbally), or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliation
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
da Vinci Patients
Consecutive enrollment of patients with indications of interest and having a da Vinci robotic-assisted surgery |
Robotic-assisted surgery (da Vinci) |
|
Epidemiological Data Audit
Extended data collection on patients with indications of interest, eligible for a robotic-assisted surgery, but treatment choice was not a da Vinci surgery |
Non-da Vinci Surgery |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of complications related to the surgery up to 30 days
大体时间:30 days
|
Describe the number of complications related to the surgery up to 30 days; adverse events as documented during the first 30 days will be classified as four different levels of causality to the surgery (not related, possible, probable and causal relationship). Descriptive analysis will be performed. |
30 days
|
|
Describe the number of patient-reported outcomes up to 12 months
大体时间:12 months
|
Describe the patient-reported outcomes up to 12 months; descriptive analysis will be performed on the data directly reported via the patients (patient questionnaires); information included are number of complications, re-hospitalizations, re-operations, disease recurrence, disease remission, new disease diagnosis and pain status including pain medication |
12 months
|
|
Characterize the treatment decision as reported by the treating physician
大体时间:30 days
|
Characterize the treatment decision per data provided by the treating physician (within the study database) including the rationale given for the treatment decision (e.g., age of the patient or co-morbidity); number of treatment decisions, e.g., for surgical therapy (open surgery or minimal-invasive therapy), watchful waiting, or treatment with medication will be described; descriptive analysis will be performed |
30 days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Investigate the impact of patient characteristics on surgery
大体时间:30 days
|
Descriptive analysis of patient characteristics such as age on surgery (e.g., duration of surgery, instrument usage) |
30 days
|
|
Investigate the impact of patient characteristics on clinical outcome
大体时间:30 days
|
Descriptive analysis of patient characteristics such as age on clinical outcome (e.g., re-operation) |
30 days
|
|
Investigate the impact of patient characteristics on complications
大体时间:30 days
|
Descriptive analysis of patient characteristics such as age on complication (number of complications reported during and after the surgery) |
30 days
|
|
Describe the impact from surgery to the patient's quality of life and function
大体时间:12 months
|
Describe the impact from surgery to the patient's quality of life and function by comparing the baseline quality of life and functional status with the post-operative status (post-operative day 1-3, 30 days, 90 days, 6 months and 12 months) |
12 months
|
|
Describe the number of Intuitive instruments used per procedure and patient characteristics
大体时间:30 days
|
Describe the number of Intuitive instruments used per procedure and patient characteristics; descriptive analysis will be performed on the number of instruments used per specific procedure and patient |
30 days
|
|
Describe the number of disease recurrence and re-operation at final patient follow-up
大体时间:12 months
|
Describe the number disease recurrence and re-operation at final patient follow-up; descriptive analysis will be performed |
12 months
|
|
Describe the number of conversion per procedure and patient characteristics
大体时间:30 days
|
Describe the number conversion per procedure and patient characteristics; descriptive analysis will be performed |
30 days
|
|
Describe the impact of surgeon experience on surgical times (duration of surgery per treating surgeon)
大体时间:30 days
|
Describe the impact of surgeon experience on surgical times, descriptive analysis will be performed on the surgical times (duration of surgery) per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on clinical outcome (number of clinical outcomes per treating surgeon)
大体时间:30 days
|
Describe the impact of surgeon experience on clinical outcome; descriptive analysis will be performed, e.g., on number of re-operation or re-hospitalization per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on complications (number of events per surgeon)
大体时间:30 days
|
Describe the impact of surgeon experience on complications; descriptive analysis will be performed on number of adverse events per treating surgeon |
30 days
|
合作者和调查者
调查人员
- 首席研究员:Ingolf Juhasz-Böss, Prof. Dr.、University Hospital Freiburg
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.